Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 2
1979 4
1980 2
1981 1
1982 4
1983 4
1984 8
1985 13
1986 13
1987 19
1988 22
1989 74
1990 49
1991 56
1992 100
1993 112
1994 130
1995 145
1996 178
1997 215
1998 209
1999 243
2000 232
2001 254
2002 277
2003 318
2004 330
2005 280
2006 333
2007 321
2008 290
2009 256
2010 273
2011 249
2012 243
2013 242
2014 227
2015 251
2016 204
2017 183
2018 191
2019 163
2020 189
2021 169
2022 4
Text availability
Article attribute
Article type
Publication date

Search Results

6,574 results
Results by year
Filters applied: . Clear all
Page 1
Paroxetine: a review.
Bourin M, Chue P, Guillon Y. Bourin M, et al. CNS Drug Rev. 2001 Spring;7(1):25-47. doi: 10.1111/j.1527-3458.2001.tb00189.x. CNS Drug Rev. 2001. PMID: 11420571 Free PMC article. Review.
Paroxetine is a potent and selective serotonin reuptake inhibitor (SSRI) with currently approved indications for the treatment of depression, obsessive-compulsive disorder, panic disorder and social phobia. ...Paroxetine exhibits some affinity for the muscarinic cho
Paroxetine is a potent and selective serotonin reuptake inhibitor (SSRI) with currently approved indications for the treatment of dep
Paroxetine hydrochloride.
Germann D, Ma G, Han F, Tikhomirova A. Germann D, et al. Profiles Drug Subst Excip Relat Methodol. 2013;38:367-406. doi: 10.1016/B978-0-12-407691-4.00008-3. Profiles Drug Subst Excip Relat Methodol. 2013. PMID: 23668408 Review.
Paroxetine hydrochloride (3S-trans)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-piperidine hydrochloride (or (-)-(3S,4R)-(4-(p-fluorophenyl)-3-[[3,4-(methylenedioxy)-phenoxy]methyl]piperidine hydrochloride), a phenylpiperidine derivative, is a selective serotoni
Paroxetine hydrochloride (3S-trans)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-piperidine hydrochloride (or (-)-(3S,4R)-(
Resolution of sexsomnia with paroxetine.
Kumar V, Grbach VX, Castriotta RJ. Kumar V, et al. J Clin Sleep Med. 2020 Jul 15;16(7):1213-1214. doi: 10.5664/jcsm.8478. J Clin Sleep Med. 2020. PMID: 32672534 Free PMC article.
To avoid the neuro-depressant effects of benzodiazepines, paroxetine was administered and resulted in complete resolution of sexsomnia....
To avoid the neuro-depressant effects of benzodiazepines, paroxetine was administered and resulted in complete resolution of sexsomni …
A review of paroxetine for the treatment of vasomotor symptoms.
Slaton RM, Champion MN, Palmore KB. Slaton RM, et al. J Pharm Pract. 2015 Jun;28(3):266-74. doi: 10.1177/0897190014544785. Epub 2014 Aug 8. J Pharm Pract. 2015. PMID: 25107421 Review.
METHODS: Both PubMed and International Pharmaceutical Abstracts (IPA) were searched using the keywords hot flashes, vasomotor symptoms, menopause, and paroxetine. In PubMed, MeSH terms were used for paroxetine, menopause, and hot flashes. ...CONCLUSION: Paroxetin
METHODS: Both PubMed and International Pharmaceutical Abstracts (IPA) were searched using the keywords hot flashes, vasomotor symptoms, meno …
Paroxetine: safety and tolerability issues.
Marks DM, Park MH, Ham BJ, Han C, Patkar AA, Masand PS, Pae CU. Marks DM, et al. Expert Opin Drug Saf. 2008 Nov;7(6):783-94. doi: 10.1517/14740330802423168. Expert Opin Drug Saf. 2008. PMID: 18983224 Review.
Paroxetine is the most potent inhibitor of serotonin re-uptake among the now available SSRIs. ...Paroxetine and paroxetine CR are not indicated for use in the paediatric population and are categorised as Pregnancy Class D. ...
Paroxetine is the most potent inhibitor of serotonin re-uptake among the now available SSRIs. ...Paroxetine and paroxetine
[Paroxetine: pharmacokinetics and pharmacodynamics].
Hiemke C. Hiemke C. Fortschr Neurol Psychiatr. 1994 Sep;62 Suppl 1:2-8. Fortschr Neurol Psychiatr. 1994. PMID: 7959522 Review. German.
Paroxetine is a trans-isomeric phenylpiperidine with antidepressant properties induced by selective inhibition of the neuronal high affinity uptake of serotonin. ...Paroxetine is applied orally at single daily doses of 20 to 50 mg and well absorbed from the gastroin
Paroxetine is a trans-isomeric phenylpiperidine with antidepressant properties induced by selective inhibition of the neuronal high a
Paroxetine-related tremor.
Lai H, Tolat R. Lai H, et al. Geriatrics. 2005 Jul;60(7):18-20. Geriatrics. 2005. PMID: 16026177 Review. No abstract available.
Paroxetine use during pregnancy: is it safe?
Thormahlen GM. Thormahlen GM. Ann Pharmacother. 2006 Oct;40(10):1834-7. doi: 10.1345/aph.1H116. Epub 2006 Aug 22. Ann Pharmacother. 2006. PMID: 16926304 Review.
Recently, paroxetine was associated with a 1.82-fold (95% CI 1.17 to 2.82) increased risk of congenital malformations compared with other antidepressants. ...The Food and Drug Administration recommendations regarding paroxetine use during pregnancy have been added t …
Recently, paroxetine was associated with a 1.82-fold (95% CI 1.17 to 2.82) increased risk of congenital malformations compared with o …
Paroxetine mesylate: comparable to paroxetine hydrochloride?
Pae CU, Misra A, Ham BJ, Han C, Patkar AA, Masand PS. Pae CU, et al. Expert Opin Pharmacother. 2010 Feb;11(2):185-93. doi: 10.1517/14656560903451708. Expert Opin Pharmacother. 2010. PMID: 20088740 Review.
IMPORTANCE OF THE FIELD: Currently available small case reports clearly propose that existing regulatory procedures to approve generic versions only require essential bioequivalence, have limitations and fail to meet stricter scientific and clinical demands. AREAS COVERED IN THIS …
IMPORTANCE OF THE FIELD: Currently available small case reports clearly propose that existing regulatory procedures to approve generic versi …
Paroxetine: a pharmacological review.
Johnson AM. Johnson AM. Int Clin Psychopharmacol. 1992 Jun;6 Suppl 4:15-24. Int Clin Psychopharmacol. 1992. PMID: 1331230 Review.
Paroxetine has been characterized as a highly potent and selective 5-hydroxytryptamine (serotonin) reuptake inhibitor. ...Furthermore, studies indicate that the metabolites of paroxetine do not contribute to its clinical effects. This profile supports the evidence f
Paroxetine has been characterized as a highly potent and selective 5-hydroxytryptamine (serotonin) reuptake inhibitor. ...Furthermore
6,574 results